Stay updated on Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial

Sign up to get notified when there's something new on the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    New revision entry added: v3.5.0. The previous revision v3.4.3 is listed as deleted.
    Difference
    0.1%
    Check dated 2026-03-25T18:40:23.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Site revision label updated from v3.4.2 to v3.4.3 in the page footer.
    Difference
    0.1%
    Check dated 2026-03-11T16:16:45.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the study record history, and Revision: v3.4.1 was removed. This is a minor update to release notes and does not alter the study information.
    Difference
    0.9%
    Check dated 2026-02-11T11:10:48.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A site-wide funding-status notice was added and the site version updated from v3.4.0 to v3.4.1.
    Difference
    0.9%
    Check dated 2026-02-04T06:25:17.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    UI enhancements include a Show glossary option and color-coded highlights for additions (green) and deletions (red) in the record history. The revision banner now displays Revision: v3.4.0.
    Difference
    1%
    Check dated 2026-01-28T04:25:42.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The page history shows a minor revision update (Revision: v3.3.4) replacing the prior version (v3.3.3) with no visible changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:47:11.000Z thumbnail image

Stay in the know with updates to Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page.